Effects of antimalarial molecules on the gametocyte stage of plasmodium falciparum: The debate

Journal of Medicinal Chemistry

Volumn 55, Issue 23, 2012, Pages 10328-10344

  Dechy Cabaret, Odile ^a,b   Benoit Vical, Françoise ^a,b,c  

^a CHU RANGUEIL   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOQUINOLINE; 8 AMINOQUINOLINE DERIVATIVE; AMINOQUINOLINE DERIVATIVE; AMODIAQUINE; AMODIAQUINE PLUS ARTESUNATE; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTESUNATE; ARTESUNATE PLUS MEFLOQUINE; ATOVAQUONE; ATOVAQUONE PLUS PROGUANIL; AZADIRACHTIN; AZITHROMYCIN; BENFLUMETOL; BULAQUINE; CHLOROQUINE; DIHYDROARTEMISININ; DIHYDROARTEMISININ PLUS PIPERAQUINE; DOXYCYCLINE; IMIDAZOQUINE DERIVATIVE; MEFLOQUINE; PIPERAQUINE; PRIMAQUINE; PRIMAQUINE DERIVATIVE; PYRIMETHAMINE PLUS SULFADOXINE; QUININE; TAFENOQUINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANOPHELES STEPHENSI; ANTIMALARIAL ACTIVITY; BACTERIAL INFECTION; CLINICAL EVALUATION; DRUG CLEARANCE; DRUG EFFECT; DRUG HALF LIFE; DRUG STRUCTURE; GAMETOCYTE; HUMAN; IN VITRO STUDY; MALARIA; MALARIA FALCIPARUM; NONHUMAN; PATIENT SAFETY; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX; REVIEW; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTIMALARIALS; GERM CELLS; PLASMODIUM FALCIPARUM;

EID: 84871027914     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm3005898     Document Type: Review

References (178)

1. World Malaria Report 2010; World Health Organization: Geneva, Switzerland, 2010; http://www.who.int/malaria/world-malaria-report-2010/ worldmalariareport2010.pdf.
2. Murray, C. J.; Rosenfeld, L. C.; Lim, S. S.; Andrews, K. G.; Foreman, K. J.; Haring, D.; Fullman, N.; Naghavi, M.; Lozano, R.; Lopez, A. D. Global malaria mortality between 1980 and 2010: a systematic analysis Lancet 2012, 379, 413-431
3. The maIERA Consultative Group on Drugs. A Research Agenda for Malaria Eradication: Drugs PLoS Med. 2011, 8, e1000402
4. Carter, R.; Miller, L. H. Evidence for environmental modulation of gametocytogenesis in Plasmodium falciparum in continuous culture Bull. W. H. O. 1979, 57, 37-52
5. Puta, C.; Manyando, C. Enhanced gametocyte production in Fansidar-treated Plasmodium falciparum malaria patients: implications for malaria transmission control programmes Trop. Med. Int. Health 1997, 2, 227-229
6. Baker, D. A. Malaria gametocytogenesis Mol. Biochem. Parasitol. 2010, 172, 57-65
7. Robert, V.; Awono-Ambene, H. P.; Le Hesran, J. Y.; Trape, J. F. Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine Am. J. Trop. Med. Hyg. 2000, 62, 210-216
8. Bruce, M. C.; Alano, P.; Duthie, S.; Carter, R. Commitment of the malaria parasite Plasmodium falciparum to sexual and asexual development Parasitology 1990, 100, 191-200
9. Price, R.; Nosten, F.; Simpson, J. A.; Luxemburger, C.; Phaipun, L.; ter Kuile, F.; van Vugt, M.; Chongsuphajaisiddhi, T.; White, N. J. Risk factors for gametocyte carriage in uncomplicated falciparum malaria Am. J. Trop. Med. Hyg. 1999, 60, 1019-1023
10. Sutherland, C. J. Comparing highly efficacious antimalarial drugs PLoS Med. 2008, 5, e228
11. Tiburcio, M.; Niang, M.; Deplaine, G.; Perrot, S.; Bischoff, E.; Ndour, P. A.; Silvestrini, F.; Khattab, A.; Milon, G.; David, P. H.; Hardeman, M.; Vernick, K. D.; Sauerwein, R. W.; Preiser, P. R.; Mercereau-Puijalon, O.; Buffet, P.; Alano, P.; Lavazec, C. A switch in infected erythrocyte deformability at the maturation and blood circulation of Plasmodium falciparum transmission stages Blood 2012, 119, e172-e180
12. Trager, W.; Jensen, J. B. Human malaria parasites in continuous culture Science 1976, 193, 673-675
13. Ifediba, T.; Vanderberg, J. P. Complete in vitro maturation of Plasmodium falciparum gametocytes Nature 1981, 294, 364-366
14. Akompong, T.; Eksi, S.; Williamson, K.; Haldar, K. Gametocytocidal activity and synergistic interactions of riboflavin with standard antimalarial drugs against growth of Plasmodium falciparum in vitro Antimicrob. Agents Chemother. 2000, 44, 3107-3111
15. Buckling, A.; Ranford-Cartwright, L. C.; Miles, A.; Read, A. F. Chloroquine increases Plasmodium falciparum gametocytogenesis in vitro Parasitology 1999, 118, 339-346
16. Chutmongkonkul, M.; Maier, W. A.; Seitz, H. M. A new model for testing gametocytocidal effects of some antimalarial drugs on Plasmodium falciparum in vitro Ann. Trop. Med. Parasitol. 1992, 86, 207-215
17. Chavalitshewinkoon-Petmitr, P.; Pongvilairat, G.; Auparakkitanon, S.; Wilairat, P. Gametocytocidal activity of pyronaridine and DNA topoisomerase II inhibitors against multidrug-resistant Plasmodium falciparum in vitro Parasitol. Int. 2000, 48, 275-280
18. Lelievre, J.; Almela, M. J.; Lozano, S.; Miguel, C.; Franco, V.; Leroy, D.; Herreros, E. Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence transmission blocking assay PLoS One 2012, 7, e35019
19. Benoit-Vical, F.; Lelievre, J.; Berry, A.; Deymier, C.; Dechy-Cabaret, O.; Cazelles, J.; Loup, C.; Robert, A.; Magnaval, J. F.; Meunier, B. Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes Antimicrob. Agents Chemother. 2007, 51, 1463-1472
20. Sinden, R. E.; Smalley, M. E. Gametocytogenesis of Plasmodium falciparum in vitro: the cell-cycle Parasitology 1979, 79, 277-296
21. Raabe, A. C.; Billker, O.; Vial, H. J.; Wengelnik, K. Quantitative assessment of DNA replication to monitor microgametogenesis in Plasmodium berghei Mol. Biochem. Parasitol. 2009, 168, 172-176
22. Chevalley, S.; Coste, A.; Lopez, A.; Pipy, B.; Valentin, A. Flow cytometry for the evaluation of anti-plasmodial activity of drugs on Plasmodium falciparum gametocytes Malar. J. 2010, 9, 49
23. Tanaka, T. Q.; Williamson, K. C. A malaria gametocytocidal assay using oxidoreduction indicator, alamarBlue Mol. Biochem. Parasitol. 2011, 177, 160-163
24. Peatey, C. L.; Leroy, D.; Gardiner, D. L.; Trenholme, K. R. Anti-malarial drugs: How effective are they against Plasmodium falciparum gametocytes? Malar. J. 2012, 11, 34
25. Berry, A.; Deymier, C.; Sertorio, M.; Witkowski, B.; Benoit-Vical, F. Pfs 16 pivotal role in Plasmodium falciparum gametocytogenesis: a potential antiplasmodial drug target Exp. Parasitol. 2009, 121, 189-192
26. Dixon, M. W.; Peatey, C. L.; Gardiner, D. L.; Trenholme, K. R. A green fluorescent protein-based assay for determining gametocyte production in Plasmodium falciparum Mol. Biochem. Parasitol. 2009, 163, 123-126
27. Peatey, C. L.; Skinner-Adams, T. S.; Dixon, M. W.; McCarthy, J. S.; Gardiner, D. L.; Trenholme, K. R. Effect of antimalarial drugs on Plasmodium falciparum gametocytes J. Infect. Dis. 2009, 200, 1518-1521
28. Buchholz, K.; Burke, T. A.; Williamson, K. C.; Wiegand, R. C.; Wirth, D. F.; Marti, M. A high-throughput screen targeting malaria transmission stages opens new avenues for drug development J. Infect. Dis. 2011, 203, 1445-1453
29. Adjalley, S. H.; Johnston, G. L.; Li, T.; Eastman, R. T.; Ekland, E. H.; Eappen, A. G.; Richman, A.; Sim, B. K.; Lee, M. C.; Hoffman, S. L.; Fidock, D. A. Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 1214-1223
30. Suhrbier, A.; Janse, C.; Mons, B.; Fleck, S. L.; Nicholas, J.; Davies, C. S.; Sinden, R. E. The complete development in vitro of the vertebrate phase of the mammalian malarial parasite Plasmodium berghei Trans. R. Soc. Trop. Med. Hyg. 1987, 81, 907-909
31. Young, J. A.; Fivelman, Q. L.; Blair, P. L.; de la Vega, P.; Le Roch, K. G.; Zhou, Y.; Carucci, D. J.; Baker, D. A.; Winzeler, E. A. The Plasmodium falciparum sexual development transcriptome: a microarray analysis using ontology-based pattern identification Mol. Biochem. Parasitol. 2005, 143, 67-79
32. Long, G. H.; Chan, B. H.; Allen, J. E.; Read, A. F.; Graham, A. L. Blockade of TNF receptor 1 reduces disease severity but increases parasite transmission during Plasmodium chabaudi chabaudi infection Int. J. Parasitol. 2008, 38, 1073-1081
33. Mulder, B.; Lensen, T.; Tchuinkam, T.; Roeffen, W.; Verhave, J. P.; Boudin, C.; Sauerwein, R. Plasmodium falciparum: membrane feeding assays and competition ELISAs for the measurement of transmission reduction in sera from Cameroon Exp. Parasitol. 1999, 92, 81-86
34. Sinden, R. Infection of Mosquitoes with Rodent Malaria. In Molecular Biology of Insect Disease Vectors: A Methods Manual; Crampton, J. M.; Beard, C. B.; Louis, C., Eds.; Chapman and Hall: London, U.K., 1997; pp 67-91.
35. Delves, M. J.; Sinden, R. E. A semi-automated method for counting fluorescent malaria oocysts increases the throughput of transmission blocking studies Malar. J. 2010, 9, 35
36. Puri, S. K.; Dutta, G. P. Plasmodium cynomolgi: gametocytocidal activity of the anti-malarial compound CDRI 80/53 (elubaquine) in rhesus monkeys Exp. Parasitol. 2005, 111, 8-13
37. Teklehaimanot, A.; Collins, W. E.; Nguyen-Dinh, P.; Campbell, C. C.; Bhasin, V. K. Characterization of Plasmodium falciparum cloned lines with respect to gametocyte production in vitro, infectivity to Anopheles mosquitoes, and transmission to Aotus monkeys Trans. R. Soc. Trop. Med. Hyg. 1987, 81, 885-887
38. Valecha, N.; Phyo, A. P.; Mayxay, M.; Newton, P. N.; Krudsood, S.; Keomany, S.; Khanthavong, M.; Pongvongsa, T.; Ruangveerayuth, R.; Uthaisil, C.; Ubben, D.; Duparc, S.; Bacchieri, A.; Corsi, M.; Rao, B. H.; Bhattacharya, P. C.; Dubhashi, N.; Ghosh, S. K.; Dev, V.; Kumar, A.; Pukittayakamee, S. An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia PLoS One 2010, 5, e11880
39. Okafor, H. U.; Shu, E. N.; Oguonu, T. Therapeutic efficacy and effect on gametocyte carriage of an artemisinin and a non-based combination treatment in children with uncomplicated P. falciparum malaria, living in an area with high-level chloroquine resistance J. Trop. Pediatr. 2010, 56, 398-406
40. Policies, Strategies and Targets for Malaria Control. World Malaria Report 2009; World Health Organization: Geneva, Switzerland, 2009; Chapter 2.
41. Babiker, H. A.; Schneider, P.; Reece, S. E. Gametocytes: insights gained during a decade of molecular monitoring Trends Parasitol. 2008, 24, 525-530
42. Ali, E.; Mackinnon, M. J.; Abdel-Muhsin, A. M.; Ahmed, S.; Walliker, D.; Babiker, H. A. Increased density but not prevalence of gametocytes following drug treatment of Plasmodium falciparum Trans. R. Soc. Trop. Med. Hyg. 2006, 100, 176-183
43. Targett, G.; Drakeley, C.; Jawara, M.; von Seidlein, L.; Coleman, R.; Deen, J.; Pinder, M.; Doherty, T.; Sutherland, C.; Walraven, G.; Milligan, P. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae J. Infect. Dis. 2001, 183, 1254-1259
44. Robert, V.; Molez, J. F.; Trape, J. F. Short report: gametocytes, chloroquine pressure, and the relative parasite survival advantage of resistant strains of falciparum malaria in West Africa Am. J. Trop. Med. Hyg. 1996, 55, 350-351
45. Vale, N.; Moreira, R.; Gomes, P. Primaquine revisited six decades after its discovery Eur. J. Med. Chem. 2009, 44, 937-953
46. Chotivanich, K.; Sattabongkot, J.; Udomsangpetch, R.; Looareesuwan, S.; Day, N. P.; Coleman, R. E.; White, N. J. Transmission-blocking activities of quinine, primaquine, and artesunate Antimicrob. Agents Chemother. 2006, 50, 1927-1930
47. Araujo, M. J.; Bom, J.; Capela, R.; Casimiro, C.; Chambel, P.; Gomes, P.; Iley, J.; Lopes, F.; Morais, J.; Moreira, R.; de Oliveira, E.; do Rosario, V.; Vale, N. Imidazolidin-4-one derivatives of primaquine as novel transmission-blocking antimalarials J. Med. Chem. 2005, 48, 888-892
48. Coleman, R.; Clavin, A.; Milhous, W. Gametocydal and sporotocidal activity of antimalarials against Plasmodium berghei anka in ICR mice and Anopheles stephensi mosquitoes Am. J. Trop. Med. Hyg. 1992, 46, 169-182
49. Pukrittayakamee, S.; Chotivanich, K.; Chantra, A.; Clemens, R.; Looareesuwan, S.; White, N. J. Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria Antimicrob. Agents Chemother. 2004, 48, 1329-1334
50. Chomcharn, Y.; Surathin, K.; Bunnag, D.; Sucharit, S.; Harinasuta, T. Effect of a single dose of primaquine on a Thai strain of Plasmodium falciparum Southeast Asian J. Trop. Med. Public Health 1980, 11, 408-412
51. Gogtay, N. J.; Kamtekar, K. D.; Dalvi, S. S.; Mehta, S. S.; Chogle, A. R.; Aigal, U.; Kshirsagar, N. A. A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria BMC Infect. Dis. 2006, 6, 16
52. Lederman, E. R.; Maguire, J. D.; Sumawinata, I. W.; Chand, K.; Elyazar, I.; Estiana, L.; Sismadi, P.; Bangs, M. J.; Baird, J. K. Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia Malar. J. 2006, 5, 108
53. Bousema, T.; Okell, L.; Shekalaghe, S.; Griffin, J. T.; Omar, S.; Sawa, P.; Sutherland, C.; Sauerwein, R.; Ghani, A. C.; Drakeley, C. Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs Malar. J. 2010, 9, 136
54. Baird, J. K.; Hoffman, S. L. Primaquine therapy for malaria Clin. Infect. Dis. 2004, 39, 1336-1345
55. Arango, E. M.; Upegui, Y. A.; Carmona-Fonseca, J. Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia Acta Trop. 2012, 122, 177-182
56. Baird, J. K.; Surjadjaja, C. Consideration of ethics in primaquine therapy against malaria transmission Trends Parasitol. 2011, 27, 11-16
57. Ganesan, S.; Chaurasiya, N. D.; Sahu, R.; Walker, L. A.; Tekwani, B. L. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway Toxicology 2012, 294, 54-60
58. Dondorp, A. M.; Yeung, S.; White, L.; Nguon, C.; Day, N. P.; Socheat, D.; von Seidlein, L. Artemisinin resistance: current status and scenarios for containment Nat. Rev. Microbiol. 2010, 8, 272-280
59. Chutmongkonkul, M.; Maier, W. A.; Seitz, H. M. Plasmodium falciparum: effect of chloroquine, halofantrine and pyrimethamine on the infectivity of gametocytes for Anopheles stephensi mosquitoes Ann. Trop. Med. Parasitol. 1992, 86, 103-110
60. Smalley, M. E. Plasmodium falciparum gametocytes: the effect of chloroquine on their development Trans. R. Soc. Trop. Med. Hyg. 1977, 71, 526-529
61. Buckling, A. G.; Taylor, L. H.; Carlton, J. M.; Read, A. F. Adaptive changes in Plasmodium transmission strategies following chloroquine chemotherapy Proc. R. Soc. London, Ser. B 1997, 264, 553-559
62. Hogh, B.; Thompson, R.; Hetzel, C.; Fleck, S. L.; Kruse, N. A.; Jones, I.; Dgedge, M.; Barreto, J.; Sinden, R. E. Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique Am. J. Trop. Med. Hyg. 1995, 52, 50-59
63. Ringwald, P.; Meche, F. S.; Basco, L. K. Short report: effects of pyronaridine on gametocytes in patients with acute uncomplicated falciparum malaria Am. J. Trop. Med. Hyg. 1999, 61, 446-448
64. von Seidlein, L.; Jawara, M.; Coleman, R.; Doherty, T.; Walraven, G.; Targett, G. Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria Trop. Med. Int. Health 2001, 6, 92-98
65. Strickland, G. T.; Fox, E.; Sarwar, M.; Khaliq, A. A.; Macdonald, M. Effects of chloroquine, amodiaquine and pyrimethamine-sulfadoxine on Plasmodium falciparum gametocytemia Am. J. Trop. Med. Hyg. 1986, 35, 259-262
66. Sokhna, C. S.; Trape, J. F.; Robert, V. Gametocytaemia in Senegalese children with uncomplicated falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine Parasite 2001, 8, 243-250
67. Nacher, M.; Silachamroon, U.; Singhasivanon, P.; Wilairatana, P.; Phumratanaprapin, W.; Fontanet, A.; Looareesuwan, S. Comparison of artesunate and chloroquine activities against Plasmodium vivax gametocytes Antimicrob. Agents Chemother. 2004, 48, 2751-2752
68. Barnes, K. I.; White, N. J. Population biology and antimalarial resistance: the transmission of antimalarial drug resistance in Plasmodium falciparum Acta Trop. 2005, 94, 230-240
69. Hogh, B.; Gamage-Mendis, A.; Butcher, G. A.; Thompson, R.; Begtrup, K.; Mendis, C.; Enosse, S. M.; Dgedge, M.; Barreto, J.; Eling, W.; Sinden, R. E. The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector Am. J. Trop. Med. Hyg. 1998, 58, 176-182
70. Osorio, L.; Ferro, B. E.; Castillo, C. M. Effects of chloroquine and sulfadoxine/pyrimethamine on gametocytes in patients with uncomplicated Plasmodium falciparum malaria in Colombia Mem. Inst. Oswaldo Cruz 2002, 97, 1221-1223
71. Hallett, R. L.; Sutherland, C. J.; Alexander, N.; Ord, R.; Jawara, M.; Drakeley, C. J.; Pinder, M.; Walraven, G.; Targett, G. A.; Alloueche, A. Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes Antimicrob. Agents Chemother. 2004, 48, 3940-3943
72. Buckling, A.; Crooks, L.; Read, A. Plasmodium chabaudi: effect of antimalarial drugs on gametocytogenesis Exp. Parasitol. 1999, 93, 45-54
73. Harinasuta, T.; Bunnag, D.; Lasserre, R.; Leimer, R.; Vinijanont, S. Trials of mefloquine in vivax and of mefloquine plus fansidar in falciparum malaria Lancet 1985, 1, 885-888
74. Price, R. N.; Nosten, F.; Luxemburger, C.; ter Kuile, F. O.; Paiphun, L.; Chongsuphajaisiddhi, T.; White, N. J. Effects of artemisinin derivatives on malaria transmissibility Lancet 1996, 347, 1654-1658
75. WHO Model Prescribing Information: Drugs Used in Parasitic Diseases, 2 nd ed.; World Health Organization: Geneva, Switzerland, 1995; http://apps.who.int/ medicinedocs/fr/d/Jh2922e/2.5.html#Jh2922e.2.5.
76. Beavogui, A. H.; Djimde, A. A.; Gregson, A.; Toure, A. M.; Dao, A.; Coulibaly, B.; Ouologuem, D.; Fofana, B.; Sacko, A.; Tekete, M.; Kone, A.; Niare, O.; Wele, M.; Plowe, C. V.; Picot, S.; Doumbo, O. K. Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali Int. J. Parasitol. 2010, 40, 1213-1220
77. Kone, A.; van de Vegte-Bolmer, M.; Siebelink-Stoter, R.; van Gemert, G. J.; Dara, A.; Niangaly, H.; Luty, A.; Doumbo, O. K.; Sauerwein, R.; Djimde, A. A. Sulfadoxine-pyrimethamine impairs Plasmodium falciparum gametocyte infectivity and Anopheles mosquito survival Int. J. Parasitol. 2010, 40, 1221-1228
78. Ndounga, M.; Mayengue, P. I.; Tahar, R.; Casimiro, P. N.; Matondo Maya, D. W.; Miakassissa-Mpassi, V.; Malonga, D. A.; Nsonde-Ntandou, F.; Mallanda, G.; Ringwald, P.; Basco, L. K.; Ntoumi, F. Efficacy of sulfadoxine-pyrimethamine, amodiaquine, and sulfadoxine-pyrimethamine-amodiaquine combination for the treatment of uncomplicated falciparum malaria in the urban and suburban areas of Brazzaville (Congo) Acta Trop. 2007, 103, 163-171
79. Schneider, P.; Bousema, T.; Omar, S.; Gouagna, L.; Sawa, P.; Schallig, H.; Sauerwein, R. (Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate Int. J. Parasitol. 2006, 36, 403-408
80. Barnes, K. I.; Little, F.; Mabuza, A.; Mngomezulu, N.; Govere, J.; Durrheim, D.; Roper, C.; Watkins, B.; White, N. J. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine- pyrimethamine resistance in falciparum malaria J. Infect. Dis. 2008, 197, 1605-1613
81. von Seidlein, L.; Milligan, P.; Pinder, M.; Bojang, K.; Anyalebechi, C.; Gosling, R.; Coleman, R.; Ude, J. I.; Sadiq, A.; Duraisingh, M.; Warhurst, D.; Alloueche, A.; Targett, G.; McAdam, K.; Greenwood, B.; Walraven, G.; Olliaro, P.; Doherty, T. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial Lancet 2000, 355, 352-357
82. Sowunmi, A.; Adedeji, A. A.; Gbotosho, G. O.; Fateye, B. A.; Happi, T. C. Effects of pyrimethamine-sulphadoxine, chloroquine plus chlorpheniramine, and amodiaquine plus pyrimethamine-sulphadoxine on gametocytes during and after treatment of acute, uncomplicated malaria in children Mem. Inst. Oswaldo Cruz 2006, 101, 887-893
83. Elbasit, A. I.; Elbashir, M. I.; Khalil, I. F.; Alifrangis, M.; Giha, H. A. The efficacy of sulfadoxine-pyrimethamine alone and in combination with chloroquine for malaria treatment in rural Eastern Sudan: the interrelation between resistance, age and gametocytogenesis Trop. Med. Int. Health 2006, 11, 604-612
84. van Vugt, M.; Leonardi, E.; Phaipun, L.; Slight, T.; Thway, K. L.; McGready, R.; Brockman, A.; Villegas, L.; Looareesuwan, S.; White, N. J.; Nosten, F. Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil Clin. Infect. Dis. 2002, 35, 1498-1504
85. Fivelman, Q. L.; Butcher, G. A.; Adagu, I. S.; Warhurst, D. C.; Pasvol, G. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria Malar. J. 2002, 1, 1
86. Fleck, S. L.; Pudney, M.; Sinden, R. E. The effect of atovaquone (566C80) on the maturation and viability of Plasmodium falciparum gametocytes in vitro Trans. R. Soc. Trop. Med. Hyg. 1996, 90, 309-312
87. Butcher, G. A.; Mendoza, J.; Sinden, R. E. Inhibition of the mosquito transmission of Plasmodium berghei by Malarone (atovaquone-proguanil) Ann. Trop. Med. Parasitol. 2000, 94, 429-436
88. Enosse, S.; Butcher, G. A.; Margos, G.; Mendoza, J.; Sinden, R. E.; Hogh, B. The mosquito transmission of malaria: the effects of atovaquone-proguanil (Malarone) and chloroquine Trans. R. Soc. Trop. Med. Hyg. 2000, 94, 77-82
89. Bosman, A.; Mendis, K. N. A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies Am. J. Trop. Med. Hyg. 2007, 77, 193-197
90. Woodrow, C. J.; Haynes, R. K.; Krishna, S. Artemisinins Postgrad. Med. J. 2005, 81, 71-78
91. Kumar, N.; Zheng, H. Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum Parasitol. Res. 1990, 76, 214-218
92. Sutherland, C. J.; Ord, R.; Dunyo, S.; Jawara, M.; Drakeley, C. J.; Alexander, N.; Coleman, R.; Pinder, M.; Walraven, G.; Targett, G. A. Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether PLoS Med. 2005, 2, e92
93. Sinclair, D.; Zani, B.; Donegan, S.; Olliaro, P.; Garner, P. Artemisinin-based combination therapy for treating uncomplicated malaria Cochrane Database Syst. Rev. 2009, CD007483
94. Adjuik, M.; Babiker, A.; Garner, P.; Olliaro, P.; Taylor, W.; White, N.; International Artemisinin Study Group. Artesunate combinations for treatment of malaria: meta-analysis Lancet 2004, 363, 9-17
95. Okell, L. C.; Drakeley, C. J.; Bousema, T.; Whitty, C. J.; Ghani, A. C. Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity PLoS Med. 2008, 5, e226
96. Makanga, M.; Krudsood, S. The clinical efficacy of artemether/ lumefantrine (Coartem) Malar. J. 2009, 8, S5
97. Adjuik, M.; Agnamey, P.; Babiker, A.; Borrmann, S.; Brasseur, P.; Cisse, M.; Cobelens, F.; Diallo, S.; Faucher, J. F.; Garner, P.; Gikunda, S.; Kremsner, P. G.; Krishna, S.; Lell, B.; Loolpapit, M.; Matsiegui, P. B.; Missinou, M. A.; Mwanza, J.; Ntoumi, F.; Olliaro, P.; Osimbo, P.; Rezbach, P.; Some, E.; Taylor, W. R. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial Lancet 2002, 359, 1365-1372
98. Fehintola, F. A.; Adedeji, A. A.; Gbotosho, G. O.; Happi, C. T.; Balogun, S. T.; Folarin, O. A.; Sijuade, A. O.; Sowunmi, A. Effects of artesunate-cotrimoxazole and amodiaquine-artesunate against asexual and sexual stages of Plasmodium falciparum malaria in Nigerian children J. Infect. Chemother. 2008, 14, 188-194
99. Sowunmi, A.; Nkogho, O. O.; Okuboyejo, T. M.; Gbotosho, G. O.; Happi, C. T.; Adewoye, E. O. Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children Malar. J. 2009, 8, 297
100. Tangpukdee, N.; Krudsood, S.; Srivilairit, S.; Phophak, N.; Chonsawat, P.; Yanpanich, W.; Kano, S.; Wilairatana, P. Gametocyte clearance in uncomplicated and severe Plasmodium falciparum malaria after artesunate-mefloquine treatment in Thailand Korean J. Parasitol. 2008, 46, 65-70
101. Oesterholt, M. J.; Alifrangis, M.; Sutherland, C. J.; Omar, S. A.; Sawa, P.; Howitt, C.; Gouagna, L. C.; Sauerwein, R. W.; Bousema, T. Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya PLoS One 2009, 4, e4364
102. Ashley, E. A.; Krudsood, S.; Phaiphun, L.; Srivilairit, S.; McGready, R.; Leowattana, W.; Hutagalung, R.; Wilairatana, P.; Brockman, A.; Looareesuwan, S.; Nosten, F.; White, N. J. Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand J. Infect. Dis. 2004, 190, 1773-1782
103. Ashley, E. A.; McGready, R.; Hutagalung, R.; Phaiphun, L.; Slight, T.; Proux, S.; Thwai, K. L.; Barends, M.; Looareesuwan, S.; White, N. J.; Nosten, F. A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria Clin. Infect. Dis. 2005, 41, 425-432
104. Hasugian, A. R.; Purba, H. L.; Kenangalem, E.; Wuwung, R. M.; Ebsworth, E. P.; Maristela, R.; Penttinen, P. M.; Laihad, F.; Anstey, N. M.; Tjitra, E.; Price, R. N. Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria Clin. Infect. Dis. 2007, 44, 1067-1074
105. Yeka, A.; Dorsey, G.; Kamya, M. R.; Talisuna, A.; Lugemwa, M.; Rwakimari, J. B.; Staedke, S. G.; Rosenthal, P. J.; Wabwire-Mangen, F.; Bukirwa, H. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda PLoS One 2008, 3, e2390
106. Kamya, M. R.; Yeka, A.; Bukirwa, H.; Lugemwa, M.; Rwakimari, J. B.; Staedke, S. G.; Talisuna, A. O.; Greenhouse, B.; Nosten, F.; Rosenthal, P. J.; Wabwire-Mangen, F.; Dorsey, G. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial PLoS Clin. Trials 2007, 2, e20
107. Karunajeewa, H. A.; Mueller, I.; Senn, M.; Lin, E.; Law, I.; Gomorrai, P. S.; Oa, O.; Griffin, S.; Kotab, K.; Suano, P.; Tarongka, N.; Ura, A.; Lautu, D.; Page-Sharp, M.; Wong, R.; Salman, S.; Siba, P.; Ilett, K. F.; Davis, T. M. A trial of combination antimalarial therapies in children from Papua New Guinea N. Engl. J. Med. 2008, 359, 2545-2557
108. Mens, P. F.; Sawa, P.; van Amsterdam, S. M.; Versteeg, I.; Omar, S. A.; Schallig, H. D.; Kager, P. A. A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin- piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in Western Kenya Malar. J. 2008, 7, 237
109. White, N. J. The role of anti-malarial drugs in eliminating malaria Malar. J. 2008, 7, S8
110. Dunyo, S.; Milligan, P.; Edwards, T.; Sutherland, C.; Targett, G.; Pinder, M. Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum PLoS Clin. Trials 2006, 1, e20
111. Bousema, J. T.; Schneider, P.; Gouagna, L. C.; Drakeley, C. J.; Tostmann, A.; Houben, R.; Githure, J. I.; Ord, R.; Sutherland, C. J.; Omar, S. A.; Sauerwein, R. W. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum J. Infect. Dis. 2006, 193, 1151-1159
112. Shekalaghe, S.; Drakeley, C.; Gosling, R.; Ndaro, A.; van Meegeren, M.; Enevold, A.; Alifrangis, M.; Mosha, F.; Sauerwein, R.; Bousema, T. Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate PLoS One 2007, 2, e1023
113. Suputtamongkol, Y.; Chindarat, S.; Silpasakorn, S.; Chaikachonpatd, S.; Lim, K.; Chanthapakajee, K.; Kaewkaukul, N.; Thamlikitkul, V. The efficacy of combined mefloquine-artesunate versus mefloquine-primaquine on subsequent development of Plasmodium falciparum gametocytemia Am. J. Trop. Med. Hyg. 2003, 68, 620-623
114. El-Sayed, B.; El-Zaki, S. E.; Babiker, H.; Gadalla, N.; Ageep, T.; Mansour, F.; Baraka, O.; Milligan, P.; Babiker, A. A randomized open-label trial of artesunate- sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in Eastern Sudan PLoS One 2007, 2, e1311
115. Smithuis, F.; Kyaw, M. K.; Phe, O.; Win, T.; Aung, P. P.; Oo, A. P.; Naing, A. L.; Nyo, M. Y.; Myint, N. Z.; Imwong, M.; Ashley, E.; Lee, S. J.; White, N. J. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial Lancet Infect. Dis. 2010, 10, 673-681
116. Lawpoolsri, S.; Klein, E. Y.; Singhasivanon, P.; Yimsamran, S.; Thanyavanich, N.; Maneeboonyang, W.; Hungerford, L. L.; Maguire, J. H.; Smith, D. L. Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations Malar. J. 2009, 8, 159
117. Myint, H. Y.; Berman, J.; Walker, L.; Pybus, B.; Melendez, V.; Baird, J. K.; Ohrt, C. Review: improving the therapeutic index of 8-aminoquinolines by the use of drug combinations: review of the literature and proposal for future investigations Am. J. Trop. Med. Hyg. 2011, 85, 1010-1014
118. Dutta, G. P.; Puri, S. K. New antimalarial drug development in India: radical curative agents CDRI80/53 (elubaquine) and WR 238605 (tafenoquine) Proc. Indian Nat. Sci. Acad. 2003, B69, 871-882
119. Pradines, B.; Mamfoumbi, M. M.; Tall, A.; Sokhna, C.; Koeck, J. L.; Fusai, T.; Mosnier, J.; Czarnecki, E.; Spiegel, A.; Trape, J. F.; Kombila, M.; Rogier, C. In vitro activity of tafenoquine against the asexual blood stages of Plasmodium falciparum isolates from Gabon, Senegal, and Djibouti Antimicrob. Agents Chemother. 2006, 50, 3225-3226
120. Puri, S. K.; Dutta, G. P. Blood schizontocidal activity of WR 238605 (tafenoquine) against Plasmodium cynomolgi and Plasmodium fragile infections in rhesus monkeys Acta Trop. 2003, 86, 35-40
121. Brueckner, R. P.; Lasseter, K. C.; Lin, E. T.; Schuster, B. G. First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial Am. J. Trop. Med. Hyg. 1998, 58, 645-649
122. Nasveld, P. E.; Edstein, M. D.; Reid, M.; Brennan, L.; Harris, I. E.; Kitchener, S. J.; Leggat, P. A.; Pickford, P.; Kerr, C.; Ohrt, C.; Prescott, W. Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects Antimicrob. Agents Chemother. 2010, 54, 792-798
123. Shiraki, H.; Kozar, M. P.; Melendez, V.; Hudson, T.; Ohrt, C.; Magill, A. J.; Lin, A. Antimalarial activity of novel 5-aryl-8-aminoquinoline derivatives J. Med. Chem. 2011, 54, 131-142
124. Ponsa, N.; Sattabongkot, J.; Kittayapong, P.; Eikarat, N.; Coleman, R. E. Transmission-blocking activity of tafenoquine (WR-238605) and artelinic acid against naturally circulating strains of Plasmodium vivax in Thailand Am. J. Trop. Med. Hyg. 2003, 69, 542-547
125. Coleman, R. E.; Nath, A. K.; Schneider, I.; Song, G. H.; Klein, T. A.; Milhous, W. K. Prevention of sporogony of Plasmodium falciparum and P. berghei in Anopheles stephensi mosquitoes by transmission-blocking antimalarials Am. J. Trop. Med. Hyg. 1994, 50, 646-653
126. Nanayakkara, N. P.; Ager, A. L., Jr.; Bartlett, M. S.; Yardley, V.; Croft, S. L.; Khan, I. A.; McChesney, J. D.; Walker, L. A. Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy] quinoline succinate Antimicrob. Agents Chemother. 2008, 52, 2130-2137
127. Delves, M.; Plouffe, D.; Scheurer, C.; Meister, S.; Wittlin, S.; Winzeler, E. A.; Sinden, R. E.; Leroy, D. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites PLoS Med. 2012, 9, e1001169
128. Puri, S. K.; Srivastava, R.; Pandey, V. C.; Sethi, N.; Dutta, G. P. Methemoglobin toxicity and hematological studies on malaria anti-relapse compound CDRI 80/53 in dogs Am. J. Trop. Med. Hyg. 1989, 41, 638-642
129. Dutta, G. P.; Puri, S. K.; Bhaduri, A. P.; Seth, M. Radical curative activity of a new 8-aminoquinoline derivative (CDRI 80/53) against Plasmodium cynomolgi B in monkeys Am. J. Trop. Med. Hyg. 1989, 41, 635-637
130. Gogtay, N. J.; Kamtekar, K. D.; Dalvi, S. S.; Chogle, A. R.; Aigal, U.; Kshirsagar, N. A. Preliminary report of the evaluation of the gametocytocidal action of bulaquine, in adult patients with acute, Plasmodium falciparum malaria Ann. Trop. Med. Parasitol. 2004, 98, 525-528
131. Krudsood, S.; Wilairatana, P.; Tangpukdee, N.; Chalermrut, K.; Srivilairit, S.; Thanachartwet, V.; Muangnoicharoen, S.; Luplertlop, N.; Brittenham, G. M.; Looareesuwan, S. Safety and tolerability of elubaquine (bulaquine, CDRI 80/53) for treatment of Plasmodium vivax malaria in Thailand Korean J. Parasitol. 2006, 44, 221-228
132. Vale, N.; Prudencio, M.; Marques, C. A.; Collins, M. S.; Gut, J.; Nogueira, F.; Matos, J.; Rosenthal, P. J.; Cushion, M. T.; do Rosario, V. E.; Mota, M. M.; Moreira, R.; Gomes, P. Imidazoquines as antimalarial and antipneumocystis agents J. Med. Chem. 2009, 52, 7800-7807
133. Vale, N.; Nogueira, F.; do Rosario, V. E.; Gomes, P.; Moreira, R. Primaquine dipeptide derivatives bearing an imidazolidin-4-one moiety at the N-terminus as potential antimalarial prodrugs Eur. J. Med. Chem. 2009, 44, 2506-2516
134. Portela, M. J.; Moreira, R.; Valente, E.; Constantino, L.; Iley, J.; Pinto, J.; Rosa, R.; Cravo, P.; do Rosario, V. E. Dipeptide derivatives of primaquine as transmission-blocking antimalarials: effect of aliphatic side-chain acylation on the gametocytocidal activity and on the formation of carboxyprimaquine in rat liver homogenates Pharm. Res. 1999, 16, 949-955
135. Vale, N.; Matos, J.; Gut, J.; Nogueira, F.; do Rosario, V.; Rosenthal, P. J.; Moreira, R.; Gomes, P. Imidazolidin-4-one peptidomimetic derivatives of primaquine: synthesis and antimalarial activity Bioorg. Med. Chem. Lett. 2008, 18, 4150-4153
136. Dechy-Cabaret, O.; Benoit-Vical, F.; Loup, C.; Robert, A.; Gornitzka, H.; Bonhoure, A.; Vial, H.; Magnaval, J. F.; Seguela, J. P.; Meunier, B. Synthesis and antimalarial activity of trioxaquine derivatives Chem.-Eur. J. 2004, 10, 1625-1636
137. Meunier, B. Hybrid molecules with a dual mode of action: dream or reality? Acc. Chem. Res. 2008, 41, 69-77
138. Robert, A.; Benoit-Vical, F.; Meunier, B. The key role of heme to trigger the antimalarial activity of trioxanes Coord. Chem. Rev. 2005, 249, 1927-1936
139. Dechy-Cabaret, O.; Benoit-Vical, F.; Robert, A.; Meunier, B. Preparation and antimalarial activities of trioxaquines, new modular molecules with a trioxane skeleton linked to a 4-aminoquinoline ChemBioChem 2000, 1, 281-283
140. Capela, R.; Cabal, G. G.; Rosenthal, P. J.; Gut, J.; Mota, M. M.; Moreira, R.; Lopes, F.; Prudencio, M. Design and evaluation of primaquine-artemisinin hybrids as a multistage antimalarial strategy Antimicrob. Agents Chemother. 2011, 55, 4698-4706
141. Guiguemde, W. A.; Shelat, A. A.; Garcia-Bustos, J. F.; Diagana, T. T.; Gamo, F. J.; Guy, R. K. Global phenotypic screening for antimalarials Chem. Biol. 2012, 19, 116-129
142. Brahmachari, G. Neem-an omnipotent plant: a retrospection ChemBioChem 2004, 5, 408-421
143. Dhar, R. Inhibition of the growth and development of asexual and sexual stages of drug-sensitive and resistant strains of the human malaria parasite Plasmodium falciparum by neem (Azadiracta indica) fractions J. Ethnopharmacol. 1998, 61, 31-39
144. Udeinya, I. J.; Brown, N.; Shu, E. N.; Udeinya, F. I.; Quakeyie, I. Fractions of an antimalarial neem-leaf extract have activities superior to chloroquine, and are gametocytocidal Ann. Trop. Med. Parasitol. 2006, 100, 17-22
145. Udeinya, J. I.; Shu, E. N.; Quakyi, I.; Ajayi, F. O. An antimalarial neem leaf extract has both schizonticidal and gametocytocidal activities Am. J. Ther. 2008, 15, 108-110
146. Lucantoni, L.; Yerbanga, R. S.; Lupidi, G.; Pasqualini, L.; Esposito, F.; Habluetzel, A. Transmission blocking activity of a standardized neem (Azadirachta indica) seed extract on the rodent malaria parasite Plasmodium berghei in its vector Anopheles stephensi Malar J. 2010, 9, 66
147. Billker, O.; Shaw, M. K.; Jones, I. W.; Ley, S. V.; Mordue, A. J.; Sinden, R. E. Azadirachtin disrupts formation of organised microtubule arrays during microgametogenesis of Plasmodium berghei J. Eukaryotic Microbiol. 2002, 49, 489-497
148. Shimizu, S.; Osada, Y.; Kanazawa, T.; Tanaka, Y.; Arai, M. Suppressive effect of azithromycin on Plasmodium berghei mosquito stage development and apicoplast replication Malar J. 2010, 9, 73
149. Aminake, M. N.; Schoof, S.; Sologub, L.; Leubner, M.; Kirschner, M.; Arndt, H. D.; Pradel, G. Thiostrepton and derivatives exhibit antimalarial and gametocytocidal activity by dually targeting parasite proteasome and apicoplast Antimicrob. Agents Chemother. 2011, 55, 1338-1348
150. Olliaro, P.; Wells, T. N. The global portfolio of new antimalarial medicines under development Clin. Pharmacol. Ther. 2009, 85, 584-595
151. Sowunmi, A.; Fateye, B. A.; Adedeji, A. A.; Fehintola, F. A.; Bamgboye, A. E.; Babalola, C. P.; Happi, T. C.; Gbotosho, G. O. Effects of antifolates-co-trimoxazole and pyrimethamine-sulfadoxine-on gametocytes in children with acute, symptomatic, uncomplicated, Plasmodium falciparum malaria Mem. Inst. Oswaldo Cruz 2005, 100, 451-455
152. Hamel, M. J.; Holtz, T.; Mkandala, C.; Kaimila, N.; Chizani, N.; Bloland, P.; Kublin, J.; Kazembe, P.; Steketee, R. Efficacy of trimethoprim- sulfamethoxazole compared with sulfadoxine-pyrimethamine plus erythromycin for the treatment of uncomplicated malaria in children with integrated management of childhood illness dual classifications of malaria and pneumonia Am. J. Trop. Med. Hyg. 2005, 73, 609-615
153. Oyakhirome, S.; Issifou, S.; Pongratz, P.; Barondi, F.; Ramharter, M.; Kun, J. F.; Missinou, M. A.; Lell, B.; Kremsner, P. G. Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria Antimicrob. Agents Chemother. 2007, 51, 1869-1871
154. Borrmann, S.; Lundgren, I.; Oyakhirome, S.; Impouma, B.; Matsiegui, P. B.; Adegnika, A. A.; Issifou, S.; Kun, J. F.; Hutchinson, D.; Wiesner, J.; Jomaa, H.; Kremsner, P. G. Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria Antimicrob. Agents Chemother. 2006, 50, 2713-2718
155. Sandor, P. S.; Afra, J.; Ambrosini, A.; Schoenen, J. Prophylactic treatment of migraine with beta-blockers and riboflavin: differential effects on the intensity dependence of auditory evoked cortical potentials Headache 2000, 40, 30-35
156. Buchholz, K.; Schirmer, R. H.; Eubel, J. K.; Akoachere, M. B.; Dandekar, T.; Becker, K.; Gromer, S. Interactions of methylene blue with human disulfide reductases and their orthologues from Plasmodium falciparum Antimicrob. Agents Chemother. 2008, 52, 183-191
157. Haynes, R. K.; Cheu, K. W.; Li, K. Y.; Tang, M. M.; Wong, H. N.; Chen, M. J.; Guo, Z. F.; Guo, Z. H.; Coghi, P.; Monti, D. A partial convergence in action of methylene blue and artemisinins: antagonism with chloroquine, a reversal with verapamil, and an insight into the antimalarial activity of chloroquine ChemMedChem 2011, 6, 1603-1615
158. Schirmer, R. H.; Coulibaly, B.; Stich, A.; Scheiwein, M.; Merkle, H.; Eubel, J.; Becker, K.; Becher, H.; Muller, O.; Zich, T.; Schiek, W.; Kouyate, B. Methylene blue as an antimalarial agent Redox Rep. 2003, 8, 272-275
159. Meissner, P. E.; Mandi, G.; Witte, S.; Coulibaly, B.; Mansmann, U.; Rengelshausen, J.; Schiek, W.; Jahn, A.; Sanon, M.; Tapsoba, T.; Walter-Sack, I.; Mikus, G.; Burhenne, J.; Riedel, K. D.; Schirmer, H.; Kouyate, B.; Muller, O. Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso Malar. J. 2005, 4, 45
160. Mandi, G.; Witte, S.; Meissner, P.; Coulibaly, B.; Mansmann, U.; Rengelshausen, J.; Schiek, W.; Jahn, A.; Sanon, M.; Wust, K.; Walter-Sack, I.; Mikus, G.; Burhenne, J.; Riedel, K. D.; Schirmer, H.; Kouyate, B.; Muller, O. Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso Trop. Med. Int. Health 2005, 10, 32-38
161. Coulibaly, B.; Zoungrana, A.; Mockenhaupt, F. P.; Schirmer, R. H.; Klose, C.; Mansmann, U.; Meissner, P. E.; Muller, O. Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial PLoS One 2009, 4, e5318
162. Meissner, P. E.; Mandi, G.; Coulibaly, B.; Witte, S.; Tapsoba, T.; Mansmann, U.; Rengelshausen, J.; Schiek, W.; Jahn, A.; Walter-Sack, I.; Mikus, G.; Burhenne, J.; Riedel, K. D.; Schirmer, R. H.; Kouyate, B.; Muller, O. Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine Malar. J. 2006, 5, 84
163. Gardner, M. J.; Hall, N.; Fung, E.; White, O.; Berriman, M.; Hyman, R. W.; Carlton, J. M.; Pain, A.; Nelson, K. E.; Bowman, S.; Paulsen, I. T.; James, K.; Eisen, J. A.; Rutherford, K.; Salzberg, S. L.; Craig, A.; Kyes, S.; Chan, M. S.; Nene, V.; Shallom, S. J.; Suh, B.; Peterson, J.; Angiuoli, S.; Pertea, M.; Allen, J.; Selengut, J.; Haft, D.; Mather, M. W.; Vaidya, A. B.; Martin, D. M.; Fairlamb, A. H.; Fraunholz, M. J.; Roos, D. S.; Ralph, S. A.; McFadden, G. I.; Cummings, L. M.; Subramanian, G. M.; Mungall, C.; Venter, J. C.; Carucci, D. J.; Hoffman, S. L.; Newbold, C.; Davis, R. W.; Fraser, C. M.; Barrell, B. Genome sequence of the human malaria parasite Plasmodium falciparum Nature 2002, 419, 498-511
164. Dixon, M. W.; Thompson, J.; Gardiner, D. L.; Trenholme, K. R. Sex in Plasmodium: a sign of commitment Trends Parasitol. 2008, 24, 168-175
165. Wu, Y.; Wang, X.; Liu, X.; Wang, Y. Data-mining approaches reveal hidden families of proteases in the genome of malaria parasite Genome Res. 2003, 13, 601-616
166. Hanada, M.; Sugawara, K.; Kaneta, K.; Toda, S.; Nishiyama, Y.; Tomita, K.; Yamamoto, H.; Konishi, M.; Oki, T. Epoxomicin, a new antitumor agent of microbial origin J. Antibiot. 1992, 45, 1746-1752
167. Kreidenweiss, A.; Kremsner, P. G.; Mordmuller, B. Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon Malar. J. 2008, 7, 187
168. Czesny, B.; Goshu, S.; Cook, J. L.; Williamson, K. C. The proteasome inhibitor epoxomicin has potent Plasmodium falciparum gametocytocidal activity Antimicrob. Agents Chemother. 2009, 53, 4080-4085
169. Tarr, S. J.; Nisbet, R. E.; Howe, C. J. Transcript-level responses of Plasmodium falciparum to thiostrepton Mol. Biochem. Parasitol. 2011, 179, 37-41
170. Yanow, S. K.; Purcell, L. A.; Pradel, G.; Sato, A.; Rodriguez, A.; Lee, M.; Spithill, T. W. Potent antimalarial and transmission-blocking activities of centanamycin, a novel DNA-binding agent J. Infect. Dis. 2008, 197, 527-534
171. Purcell, L. A.; Yanow, S. K.; Lee, M.; Spithill, T. W.; Rodriguez, A. Chemical attenuation of Plasmodium berghei sporozoites induces sterile immunity in mice Infect. Immun. 2008, 76, 1193-1199
172. Chavalitshewinkoon-Petmitr, P.; Pongvilairat, G.; Ralph, R. K.; Denny, W. A.; Wilairat, P. Inhibitory effects of 9-anilinoacridines on Plasmodium falciparum gametocytes Trop. Med. Int. Health 2001, 6, 42-45
173. Auparakkitanon, S.; Chapoomram, S.; Kuaha, K.; Chirachariyavej, T.; Wilairat, P. Targeting of hematin by the antimalarial pyronaridine Antimicrob. Agents Chemother. 2006, 50, 2197-2200
174. Vivas, L.; Rattray, L.; Stewart, L.; Bongard, E.; Robinson, B. L.; Peters, W.; Croft, S. L. Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo Acta Trop. 2008, 105, 222-228
175. Silvestrini, F.; Bozdech, Z.; Lanfrancotti, A.; Di Giulio, E.; Bultrini, E.; Picci, L.; Derisi, J. L.; Pizzi, E.; Alano, P. Genome-wide identification of genes upregulated at the onset of gametocytogenesis in Plasmodium falciparum Mol. Biochem. Parasitol. 2005, 143, 100-110
176. Moreira, C. K.; Marrelli, M. T.; Jacobs-Lorena, M. Gene expression in Plasmodium: from gametocytes to sporozoites Int. J. Parasitol. 2004, 34, 1431-1440
177. Olivieri, A.; Camarda, G.; Bertuccini, L.; van de Vegte-Bolmer, M.; Luty, A. J.; Sauerwein, R.; Alano, P. The Plasmodium falciparum protein Pfg27 is dispensable for gametocyte and gamete production, but contributes to cell integrity during gametocytogenesis Mol. Microbiol. 2009, 73, 180-193
178. Dondorp, A. M.; Nosten, F.; Yi, P.; Das, D.; Phyo, A. P.; Tarning, J.; Lwin, K. M.; Ariey, F.; Hanpithakpong, W.; Lee, S. J.; Ringwald, P.; Silamut, K.; Imwong, M.; Chotivanich, K.; Lim, P.; Herdman, T.; An, S. S.; Yeung, S.; Singhasivanon, P.; Day, N. P.; Lindegardh, N.; Socheat, D.; White, N. J. Artemisinin resistance in Plasmodium falciparum malaria N. Engl. J. Med. 2009, 361, 455-467